Revive Therapeutics Ltd C.RVV

Alternate Symbol(s): RVVTF

Healthcare Biotechnology

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).

CSE:RVV - Post by User

Revive Therapeutics Ltd > USA HITS 1 million covid infections per day

<< Previous

Bullboard Posts

Next >>

Comment by 1ottrunneron Jan 04, 2022 1:14pm

89 Views

Post# 34282246

RE:RE:RE:RE:RE:RE:USA HITS 1 million covid infections per day

1. Who takes Tylenol for a cold? In a big year I may have 5 advil/tylenol/aspirin.

2. There is ZERO chance that Bucillamine replaces Tylenol for any malaise currently addressed by Tylenol. ZERO!